European Thyroid Journal最新文献

筛选
英文 中文
Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study. 硒水平及其与妊娠期甲状腺自身免疫和严重子痫前期的关系:前瞻性理想母乳队列研究的启示
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-07-09 Print Date: 2024-08-01 DOI: 10.1530/ETJ-24-0007
Chae Won Chung, Kyungsik Kim, Sue K Park, Dal Lae Ju, Young Joo Park, Choong Ho Shin, Jong Kwan Jun, June-Key Chung, Yoon Ju Song, Young Ah Lee, Gi Jeong Cheon, Sun Wook Cho
{"title":"Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study.","authors":"Chae Won Chung, Kyungsik Kim, Sue K Park, Dal Lae Ju, Young Joo Park, Choong Ho Shin, Jong Kwan Jun, June-Key Chung, Yoon Ju Song, Young Ah Lee, Gi Jeong Cheon, Sun Wook Cho","doi":"10.1530/ETJ-24-0007","DOIUrl":"10.1530/ETJ-24-0007","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess selenium status in South Korean pregnant women and its impact on maternal thyroid function and pregnancy outcomes.</p><p><strong>Methods: </strong>'Ideal Breast Milk (IBM) Cohort Study' included 367 pregnant women out of 442 participants and categorized into three groups based on plasma selenium levels: deficient (< 70 μg/L), suboptimal (70-99 μg/L), and optimal (≥ 100 μg/L). During the second or third trimester, various blood parameters, including selenium, thyroid-stimulating hormone, free T4, free T3, and anti-thyroid peroxidase antibody levels, were measured. Thyroid parenchymal echogenicity was assessed as another surrogate marker for thyroid autoimmunity using ultrasonography.</p><p><strong>Results: </strong>The median plasma selenium was 98.8 (range: 46.7-206.4) μg/L, and 30 individuals (8%) were categorized as deficient, while 164 (45%) were classified in the suboptimal group. Selenium deficiency was associated with markers of autoimmune thyroiditis, including positive anti-thyroid peroxidase antibody results (13.3 (deficient) vs 4.6 (optimal) %, P = 0.031) and thyroid parenchymal heterogeneity on ultrasound (33.3 (deficient) vs 14.6 (suboptimal) vs 17.3 (optimal) %, P = 0.042), independently of gestational age. The incidence of severe preeclampsia was higher in the group not taking selenium supplements, particularly among those with twin pregnancies, compared to the group taking selenium supplements (0 (selenium supplement) vs 9.0 (no supplement) %, P = 0.015).</p><p><strong>Conclusion: </strong>Pregnant women experience mild selenium deficiency, which can lead to significant health issues including maternal thyroid autoimmunity and obstetrical complications during pregnancy. Guidelines for appropriate selenium intake according to the stage of pregnancy and the number of fetuses are needed.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141418495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease. 新发症状性甲状腺眼病中甲状腺刺激免疫球蛋白的流行病学。
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-07-03 Print Date: 2024-08-01 DOI: 10.1530/ETJ-23-0129
Kenneth Ka Hei Lai, Fatema Mohamed Ali Abdulla Aljufairi, Jake Uy Sebastian, Yingying Wei, Ruofan Jia, Karen Kar Wun Chan, Elaine Yuen Ling Au, Alan Chun Hong Lee, Chiu Ming Ng, Hunter Kwok Lai Yuen, Wilson Wai Kuen Yip, Alvin Lerrmann Young, George Pak Man Cheng, Clement Chee Yung Tham, Chi Pui Pang, Kelvin Kam Lung Chong
{"title":"Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.","authors":"Kenneth Ka Hei Lai, Fatema Mohamed Ali Abdulla Aljufairi, Jake Uy Sebastian, Yingying Wei, Ruofan Jia, Karen Kar Wun Chan, Elaine Yuen Ling Au, Alan Chun Hong Lee, Chiu Ming Ng, Hunter Kwok Lai Yuen, Wilson Wai Kuen Yip, Alvin Lerrmann Young, George Pak Man Cheng, Clement Chee Yung Tham, Chi Pui Pang, Kelvin Kam Lung Chong","doi":"10.1530/ETJ-23-0129","DOIUrl":"10.1530/ETJ-23-0129","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to report correlations between thyroid-stimulating immunoglobulin (TSI) and both clinical and radiological parameters in recent-onset symptomatic thyroid eye disease (TED) patients.</p><p><strong>Methods: </strong>A prospective cohort study of TED patients managed at the Chinese University of Hong Kong from January 2014 to May 2022. Serum TSI levels were determined with the functional assay. Outcomes included the Clinical Activity Score (CAS), marginal reflex distance1 (MRD1), extraocular muscle motility restriction (EOMy), exophthalmos, and diplopia. The radiological assessment included cross-sectional areas and signal of extraocular muscles on STIR-sequence MRI.</p><p><strong>Results: </strong>A total of 255 (197 female) treatment-naive patients, with an average onset age of 50 ± 14 years (mean ± s.d.), were included. Elevated pre-treatment TSI level was observed in 223 (88%) patients. There was a weak positive correlation between TSI and CAS (r = 0.28, P = 0.000031), MRD1 (r = 0.17, P = 0.0080), and the size of the levator palpebrae superioris/superior rectus complex (r = 0.25, P = 0.018). No significant correlation existed between TSI and STIR signals. The AUC and optimal cut-off value for clinical active TED were 0.67 (95% CI: 0.60-0.75) and 284% (specificity: 50%, sensitivity: 85%). In total, 64 patients received intravenous methylprednisolone (IVMP) during the study interval, and they had a higher baseline TSI level than those who did not have IVMP (P = 0.000044). Serial post-IVMP TSI among the 62 patients showed a significant reduction compared to the baseline level (P < 0.001). Both the baseline and post-IVMP TSI levels, and percentages of TSI changes were comparable between patients who responded and did not respond to the first course of IVMP.</p><p><strong>Conclusion: </strong>TSI can be a serum biomarker for the diagnosis, prognosis, and treatment response of TED. Further validation should be warranted.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INCIDENTALLY VS. NON-INCIDENTALLY DIAGNOSED PAPILLARY THYROID CARCINOMA: ARE THERE DIFFERENCES? 偶然与非偶然诊断的甲状腺乳头状癌甲状腺乳头状癌:是否存在差异?
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-07-01 DOI: 10.1530/ETJ-24-0106
Inês Cosme, Ana Figueiredo, Sara Pinheiro, Valeriano Leite
{"title":"INCIDENTALLY VS. NON-INCIDENTALLY DIAGNOSED PAPILLARY THYROID CARCINOMA: ARE THERE DIFFERENCES?","authors":"Inês Cosme, Ana Figueiredo, Sara Pinheiro, Valeriano Leite","doi":"10.1530/ETJ-24-0106","DOIUrl":"10.1530/ETJ-24-0106","url":null,"abstract":"<p><p>Thyroid carcinoma (TC) incidence increased over the past 50 years. The explanation for this is not consensual.</p><p><strong>Objective: </strong>Compare incidental vs. non-incidental TC (ITC vs. NITC) regarding demographic, clinical, histological data and 5-year clinical outcomes.</p><p><strong>Design: </strong>Retrospective analysis of 225 papillary TC (PTC) cases that completed a 5-year follow-up.</p><p><strong>Methods: </strong>Created 2 groups: ITC (including the incidentalomas) and NITC (cases of palpable or visible nodules or with thyroid compressive complaints).</p><p><strong>Results: </strong>Included 225 PTC (122 were ITC). There were 95 women in ITC and 78 in NITC. ITC patients were significantly older (53.3±14.8 vs 47.2±17.7, p=0.006). Groups had no differences in family history of TC. ITC mean tumour size was smaller (19.1±9.2 vs 28.6±16.2, p<0.01). Tumours >20mm comprised 36.1% of ITC and 58.2% of NITC. We found no differences in tumour multifocality, histological thyroiditis, aggressive PTC subtypes, capsule or lymph-vascular invasion and gross extrathyroidal extension. There were no differences regarding the number of patients submitted to RAI or in RAI activity. pTMN staging showed higher prevalence of T3a and T4 cases (p<0.01), and M1 status (p=0.025) in NITC. There were no differences in the rates of persistence of disease. Logistic regression showed that the diagnostic modality had no impact on the 5-year clinical outcome.</p><p><strong>Conclusions: </strong>ITC patients were older and had smaller tumours. NITC showed no worst histological features or 5-year clinical outcome. Approximately, one third of ITC had diameters >20mm. As even large tumours can be ITC, overdiagnosis can be the most likely cause for the TC increasing incidence.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141537798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study. SARS-CoV-2时代的亚急性甲状腺炎:一项多中心前瞻性研究。
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-06-24 Print Date: 2024-06-01 DOI: 10.1530/ETJ-24-0083
Sara De Vincentis, Simona Loiacono, Eleonora Zanni, Roberta Sueri, Maria Laura Monzani, Daniele Santi, Ilaria Muller, Francesco Di Marco, Erica Crivicich, Mirco Armenti, Uberto Pagotto, Lorenzo Tucci, Carolina Cecchetti, Tommaso Trenti, Valentina Pecoraro, Giulia Canu, Manuela Simoni, Giulia Brigante
{"title":"Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.","authors":"Sara De Vincentis, Simona Loiacono, Eleonora Zanni, Roberta Sueri, Maria Laura Monzani, Daniele Santi, Ilaria Muller, Francesco Di Marco, Erica Crivicich, Mirco Armenti, Uberto Pagotto, Lorenzo Tucci, Carolina Cecchetti, Tommaso Trenti, Valentina Pecoraro, Giulia Canu, Manuela Simoni, Giulia Brigante","doi":"10.1530/ETJ-24-0083","DOIUrl":"10.1530/ETJ-24-0083","url":null,"abstract":"<p><strong>Objective: </strong>Many cases of subacute thyroiditis (SAT) have been described related to SARS-CoV-2 infection, but no prospective data about follow-up are known. This prospective, longitudinal, 3-year, multicentre study aims to explore the clinical peculiarities and outcome of SAT in relation to SARS-CoV-2 infection, ascertained with antibody dosage.</p><p><strong>Methods: </strong>All patients receiving SAT diagnosis from November 2020 to May 2022 were enrolled. Data on anamnesis, physical examination, blood tests (TSH, freeT4, freeT3, thyroglobulin, anti-thyroid antibodies, C-reactive protein, erythrocyte sedimentation rate, complete blood count), and thyroid ultrasound were collected. At baseline, the presence of IgG against the SARS-CoV-2 spike protein or nucleocapsid was investigated. Patients were evaluated after 1, 3, 6, and 12 months.</p><p><strong>Results: </strong>Sixty-six subjects were enrolled. At baseline, 54 presented with pain, 36 (67%) for at least 15 days. Serum SARS-CoV-2 IgG measurements documented that 7 out of 52 subjects (13.5%) had infection before SAT diagnosis (COVID+). No significant differences between the COVID+ and COVID- groups were found at baseline, except for respiratory symptoms and fever, which were more common in COVID+ (P = 0.039 and P = 0.021, respectively). Among the 41 subjects who completed follow-up, COVID+ and COVID- did not differ for therapeutic approach to SAT or outcome, all having an improvement in neck pain, inflammation parameters, and ultrasound features.</p><p><strong>Conclusion: </strong>This is the first prospective study investigating any difference both at diagnosis and at follow-up between SAT presentation in patients with previous SARS-CoV-2 infection and those without. Our data demonstrate that SARS-CoV-2 does not impact on SAT onset, evolution, and outcome.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141261894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term hypothyroidism in patients started on levothyroxine during pregnancy. 怀孕期间开始服用左甲状腺素的患者长期甲状腺功能减退。
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-06-20 Print Date: 2024-06-01 DOI: 10.1530/ETJ-24-0051
Sophie Demartin, Stefan Matei Constantinescu, Kris G Poppe, Dominique Maiter, Raluca Maria Furnica, Orsalia Alexopoulou, Chantal Daumerie, Frederic Debiève, Maria-Cristina Burlacu
{"title":"Long-term hypothyroidism in patients started on levothyroxine during pregnancy.","authors":"Sophie Demartin, Stefan Matei Constantinescu, Kris G Poppe, Dominique Maiter, Raluca Maria Furnica, Orsalia Alexopoulou, Chantal Daumerie, Frederic Debiève, Maria-Cristina Burlacu","doi":"10.1530/ETJ-24-0051","DOIUrl":"10.1530/ETJ-24-0051","url":null,"abstract":"<p><strong>Background: </strong>Current guidelines recommend different postpartum approaches for patients started on levothyroxine (LT4) during pregnancy.</p><p><strong>Objective: </strong>We studied the postpartum management of these patients and determined factors associated with long-term hypothyroidism.</p><p><strong>Methods: </strong>A retrospective study was conducted at a tertiary center between 2014 and 2020, with LT4 initiation according to 2014 ETA recommendations. We performed multivariate logistic regression (MVR) and a receiver operating characteristic curve analysis to determine variables associated with long-term hypothyroidism and their optimal cutoffs.</p><p><strong>Results: </strong>LT4 was initiated in 177 pregnant women, and 106/177 (60%) were followed at long-term (at least 6 months post partum) (28.5 (9.0-81.9) months). LT4 could have been stopped in 45% of patients who continued it immediately after delivery. Thirty-six out of 106 (34%) patients were long-term hypothyroid. In them, LT4 was initiated earlier during pregnancy than in euthyroid women (11.7 ± 4.7 vs 13.7 ± 6.5 weeks, P = 0.077), at a higher thyroid-stimulating hormone (TSH) level (4.1 (2.2-10.1) vs 3.5 (0.9-6.9) mU/L, P = 0.005), and reached a higher dose during pregnancy (62.8 ± 22.2 vs 50.7 ± 13.9 µg/day, P = 0.005). In the MVR, only the maximal LT4 dose during pregnancy was associated with long-term hypothyroidism (odds ratio (OR) = 1.03, 95% CI: 1.00-1.05, P = 0.003). The optimal cutoffs for predicting long-term hypothyroidism were an LT4 dose of 68.75 µg/day (87% specificity, 42% sensitivity; P = 0.013) and a TSH level ≥ 3.8 mU/L (68.5% specificity, 77% sensitivity; P = 0.019).</p><p><strong>Conclusion: </strong>One-third of the patients who started on LT4 during pregnancy had long-term hypothyroidism. The TSH level at treatment initiation and the LT4 dose during pregnancy could guide the decision for continuing long-term LT4.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New insights into the hypothalamic-pituitary-thyroid axis: a transcriptome- and proteome-wide association study. 下丘脑-垂体-甲状腺轴的新发现:转录组和全蛋白质组关联研究。
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-06-20 Print Date: 2024-06-01 DOI: 10.1530/ETJ-24-0067
Sara Monteiro-Martins, Rosalie B T M Sterenborg, Oleg Borisov, Nora Scherer, Yurong Cheng, Marco Medici, Anna Köttgen, Alexander Teumer
{"title":"New insights into the hypothalamic-pituitary-thyroid axis: a transcriptome- and proteome-wide association study.","authors":"Sara Monteiro-Martins, Rosalie B T M Sterenborg, Oleg Borisov, Nora Scherer, Yurong Cheng, Marco Medici, Anna Köttgen, Alexander Teumer","doi":"10.1530/ETJ-24-0067","DOIUrl":"10.1530/ETJ-24-0067","url":null,"abstract":"<p><strong>Introduction: </strong>Thyroid hormones have systemic effects on the human body and play a key role in the development and function of virtually all tissues. They are regulated via the hypothalamic-pituitary-thyroid (HPT) axis and have a heritable component. Using genetic information, we applied tissue-specific transcriptome-wide association studies (TWAS) and plasma proteome-wide association studies (PWAS) to elucidate gene products related to thyrotropin (TSH) and free thyroxine (FT4) levels.</p><p><strong>Results: </strong>TWAS identified 297 and 113 transcripts associated with TSH and FT4 levels, respectively (25 shared), including transcripts not identified by genome-wide association studies (GWAS) of these traits, demonstrating the increased power of this approach. Testing for genetic colocalization revealed a shared genetic basis of 158 transcripts with TSH and 45 transcripts with FT4, including independent, FT4-associated genetic signals within the CAPZB locus that were differentially associated with CAPZB expression in different tissues. PWAS identified 18 and ten proteins associated with TSH and FT4, respectively (HEXIM1 and QSOX2 with both). Among these, the cognate genes of five TSH- and 7 FT4-associated proteins mapped outside significant GWAS loci. Colocalization was observed for five plasma proteins each with TSH and FT4. There were ten TSH and one FT4-related gene(s) significant in both TWAS and PWAS. Of these, ANXA5 expression and plasma annexin A5 levels were inversely associated with TSH (PWAS: P = 1.18 × 10-13, TWAS: P = 7.61 × 10-12 (whole blood), P = 6.40 × 10-13 (hypothalamus), P = 1.57 × 10-15 (pituitary), P = 4.27 × 10-15 (thyroid)), supported by colocalizations.</p><p><strong>Conclusion: </strong>Our analyses revealed new thyroid function-associated genes and prioritized candidates in known GWAS loci, contributing to a better understanding of transcriptional regulation and protein levels relevant to thyroid function.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations. 亚临床甲状腺功能亢进症指南的系统性回顾:建议范围之广令人瞩目。
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-06-13 Print Date: 2024-06-01 DOI: 10.1530/ETJ-24-0036
Stan R Ursem, Anita Boelen, Eveline Bruinstroop, Petra J M Elders, Jacobijn Gussekloo, Rosalinde K E Poortvliet, Annemieke C Heijboer, Wendy P J den Elzen
{"title":"A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations.","authors":"Stan R Ursem, Anita Boelen, Eveline Bruinstroop, Petra J M Elders, Jacobijn Gussekloo, Rosalinde K E Poortvliet, Annemieke C Heijboer, Wendy P J den Elzen","doi":"10.1530/ETJ-24-0036","DOIUrl":"10.1530/ETJ-24-0036","url":null,"abstract":"<p><strong>Background: </strong>Subclinical thyroid diseases are often the subject of debate concerning their clinical significance, the appropriateness of diagnostic testing, and possible treatment. This systematic review addresses the variation in international guidelines for subclinical hyperthyroidism, focusing on diagnostic workup, treatment, and follow-up recommendations.</p><p><strong>Methods: </strong>Following the PRISMA guidelines, we searched PubMed, Embase, and guideline-specific databases and included clinical practice guidelines with recommendations on subclinical hyperthyroidism. Guideline recommendations were extracted, and quality assessment was performed using selected questions of the Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument.</p><p><strong>Results: </strong>Of the 2624 records screened, 22 guidelines were included, which were published between 2007 and 2021. Guideline quality was generally intermediate to low. Diagnostic approaches differed substantially, particularly in the extent of recommended testing. Treatment initiation depended on TSH levels, age, and comorbidities, but the level of detail regarding defining precise comorbidities varied. Recommendations for monitoring intervals for follow-up ranged from 3 to 12 months.</p><p><strong>Conclusion: </strong>This review underscores the existing variability in (inter)national guidelines concerning subclinical hyperthyroidism. There isa need for clear recommendations in guidelines considering diagnostic workup, treatment, and follow-up of subclinical hyperthyroidism. In order to establish this, future research should focus on determining clear and evidence-based intervention thresholds.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolutionary analysis of indeterminate cytology and risk of malignancy in a thyroid nodule unit. 甲状腺结节科中不确定细胞学和恶性肿瘤风险的演变分析。
IF 3.5 2区 医学
European Thyroid Journal Pub Date : 2024-05-01 DOI: 10.1530/ETJ-24-0076
Ana Isabel Alvarez-Mancha, Isabel Mancha-Doblas, María Molina-Vega, Diego Fernández-García, Ana María Gómez-Pérez, Elena Gallego, María Victoria Ortega-Jiménez, Isabel Hierro-Martín, Francisco J Tinahones
{"title":"Evolutionary analysis of indeterminate cytology and risk of malignancy in a thyroid nodule unit.","authors":"Ana Isabel Alvarez-Mancha, Isabel Mancha-Doblas, María Molina-Vega, Diego Fernández-García, Ana María Gómez-Pérez, Elena Gallego, María Victoria Ortega-Jiménez, Isabel Hierro-Martín, Francisco J Tinahones","doi":"10.1530/ETJ-24-0076","DOIUrl":"10.1530/ETJ-24-0076","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to analyze the evolution in the diagnosis and management of indeterminate thyroid nodules over three time periods.</p><p><strong>Methods: </strong>3020 patients with thyroid nodules underwent cytological evaluation during three periods (2006-2008, 2012-2014, 2017-2019). Distribution of diagnostic cytologies, risk of malignancy, diagnostic performance indices of FNA, and cytologic-histologic correlation in indeterminate cytologies were analyzed.</p><p><strong>Results: </strong>only 2.2% of cytology tests were insufficient for a diagnosis. 86.9% cytologies were benign, 1.7% malignant, and 11.4% indeterminate. Indeterminate cytology rates were 15.9% (2006-2008), 10.1% (2012-2014), and 10% (2017-2019). Surgery was performed in 13% of benign cytology, result-ing in malignant histology in 2.7%. All malignant and suspicious cytologies underwent surgery: malig-nancy confirmed in 98% and 77% of cases, respectively. All 'indeterminate with atypia' cytologies (2006-2008) and Bethesda IV (2012-2014; 2017-2019) un-derwent surgery, with malignancy confirmed in 19.6%, 43.8%, and 25.7%, respectively. In the 'inde-terminate without atypia' category (2006-2008) and Bethesda III (2012-2014; 2017-2019), diagnostic surgery was performed in 57.7%, 78.6%, and 59.4%, respectively, with malignancy confirmed in 3.3%, 20.5%, and 31.6%. The FNA sensitivity was 91.6% with a negative predictive value greater than 96% in all periods. The specificity exceeded 75% in the last two periods.</p><p><strong>Conclusion: </strong>Bethesda system reduces indeterminate cytologies and improves the accuracy of FNA diagnosis. We reported a higher proportion of malignancy than expected in Bethesda III, underscoring the importance of having institution-specific data to guide decision-making. However, there is a need for risk stratification tools that allow for conservative management in low-risk cases.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Langerhans Cell Histiocytosis of the Suprasellar Region: Diagnosis on Thyroid Cytology 星状上区朗格汉斯细胞组织细胞增生症:甲状腺细胞学诊断
IF 4.7 2区 医学
European Thyroid Journal Pub Date : 2024-05-01 DOI: 10.1530/etj-24-0011
Maria Mavromati, Verdiana Caironi, Essia Saiji, Maria-Isabel Vargas, Shahan Momjian, Stephanie Andrade-Lopes, Capucine Gubert, Marco Stefano Demarchi, Ismini Mainta, François R. Jornayvaz, Kaveh Samii, Grégoire Stalder, Sophie Leboulleux
{"title":"Langerhans Cell Histiocytosis of the Suprasellar Region: Diagnosis on Thyroid Cytology","authors":"Maria Mavromati, Verdiana Caironi, Essia Saiji, Maria-Isabel Vargas, Shahan Momjian, Stephanie Andrade-Lopes, Capucine Gubert, Marco Stefano Demarchi, Ismini Mainta, François R. Jornayvaz, Kaveh Samii, Grégoire Stalder, Sophie Leboulleux","doi":"10.1530/etj-24-0011","DOIUrl":"https://doi.org/10.1530/etj-24-0011","url":null,"abstract":"<p>Langerhans cell histiocytosis (LCH) may present as unifocal disease of the suprasellar region, with symptoms and signs of hypopituitarism, arginine vasopressin deficiency (AVP-D) and weight gain. Transcranial biopsy is necessary, to define diagnosis and guide treatment decisions, but is associated with significant morbidity. We describe a patient with Hashimoto thyroiditis and a single hypothalamic mass in whom LCH diagnosis was done through thyroid fine-needle aspiration cytology (FNAC) performed despite nonspecific findings in thyroid imaging, on the basis of a slightly elevated [18F]-fluorodeoxyglucose avidity on positron emission tomography/-computed tomography (FDG-PET/-CT), and volume increase during follow-up.\u0000</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":"11 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140886958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies. 抗 TPO 抗体阴性妇女中孕产妇肥胖与怀孕头三个月促甲状腺激素之间的关系。
IF 4.7 2区 医学
European Thyroid Journal Pub Date : 2024-04-18 Print Date: 2024-04-01 DOI: 10.1530/ETJ-23-0213
Laura Croce, Fausta Beneventi, Federica Ripepi, Irene De Maggio, Alberto Malovini, Camilla Bellingeri, Francesca Coperchini, Marsida Teliti, Mario Rotondi, Arsenio Spinillo, Flavia Magri
{"title":"Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies.","authors":"Laura Croce, Fausta Beneventi, Federica Ripepi, Irene De Maggio, Alberto Malovini, Camilla Bellingeri, Francesca Coperchini, Marsida Teliti, Mario Rotondi, Arsenio Spinillo, Flavia Magri","doi":"10.1530/ETJ-23-0213","DOIUrl":"10.1530/ETJ-23-0213","url":null,"abstract":"<p><strong>Objective: </strong>Obesity is associated with increased thyroid-stimulating hormone (TSH) in non-pregnant subjects, but this phenomenon has not been fully characterized during pregnancy. Our aim was to evaluate the impact of BMI on first-trimester TSH in a wide cohort of pregnant women with negative anti-thyroperoxidase antibodies (AbTPO) and its implications on uterine artery pulsatility index (UtA-PI), a marker of early placentation.</p><p><strong>Methods: </strong>The study included 2268 AbTPO-negative pregnant women at their first antenatal visit. Anamnestic data, BMI, TSH, anti-nuclear antibody (ANA) and extractable nuclear antigen (ENA) positivity and mean UtA-PI were collected.</p><p><strong>Results: </strong>A total of 1693 women had normal weight, 435 were overweight and 140 were obese. Maternal age, ANA/ENA positivity, history of autoimmune diseases and familiar history of thyroid diseases were similar in the three groups. TSH was significantly higher in obese women (1.8 (IQR: 1.4-2.4) mU/L) when compared to normal weight (1.6 (IQR: 1.2-2.2) mU/L) and overweight (median: 1.6 (IQR: 1.2-2.2) mU/L) ones (P < 0.001). BMI was significantly related with the risk of having a TSH level ≥4 mU/L at logistic regression, independently from non-thyroid autoimmunity, smoking or familiar predisposition for thyroid diseases (OR: 1.125, 95% CI: 1.080-1.172, P < 0.001). A restricted cubic splines regression showed a non-linear relationship between BMI and TSH. Women with a TSH ≥4 mU/L had a higher UtA-PI, independently from BMI.</p><p><strong>Conclusion: </strong>Overweight/obesity is significantly related with TSH serum levels in AbTPO-negative pregnant women, independently from the other risk factors for hypothyroidism during pregnancy. The increase of TSH levels could be clinically relevant, as suggested by its association with abnormal UtA-PI, a surrogate marker of abnormal placentation.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11046355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信